EUVIMEDEUVIMED entdecken
Crossref

Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high‐frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis

Harumi Nakamura iD, Yoji Kukita iD, Nobuyoshi Kittaka, Hiroki Kusama, Takahiro Nakayama, Yasuhiro Tamaki, Ken-Ichi Yoshida, Kei Kunimasa, Fumio Imamura, Toshinari Yagi

Histopathology · 2026

DOI: 10.1111/his.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Harumi Nakamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Apocrine carcinoma ( AC ) is a rare and distinct subtype of invasive breast carcinoma, typically characterized by androgen receptor ( AR ) positivity and negative expression of oestrogen and progesterone receptors. This study aimed to clarify the metabolic and molecular characteristics of AC , with a particular focus on protein expression related to lipid metabolism and the frequency and nature of PIK3CA mutations.

Methods

We analysed tissue specimens from 40 cases with AC and 59 cases with other breast cancer subtypes ( ER +/ HER2 −, ER +/ HER2 +, ER −/ HER2 + and triple‐negative breast cancer [ TNBC ]). Immunohistochemistry was performed for a panel of lipid metabolism‐related proteins including FASN , AMACR , ACOX1 , ACSL1 and catalase. mRNA Expression of ACSL1 was assessed by RT ‐ qPCR and PIK3CA mutations were analysed via targeted sequencing.

Results

AC showed significantly higher expression of enzymes involved in fatty acid synthesis and peroxisomal β‐oxidation compared to other subtypes. Notably, ACSL1 was upregulated at both protein and mRNA levels, and catalase was upregulated at the protein level, indicating an increase in peroxisomes. PIK3CA Mutations, particularly the hotspot p. H1047R variant, were detected at a significantly higher frequency in AC (68.4%) compared to the other subtypes: ER +/ HER2 − (52.6%), ER +/ HER2 + (27.3%), ER −/ HER2 + (50.0%) and TNBC (33.3%) ( P < 0.05).

Conclusions

AC is characterized by distinct metabolic reprogramming, with preferential upregulation of peroxisomal β‐oxidation rather than mitochondrial pathways. These metabolic features are accompanied by a high prevalence of activating PIK3CA mutations, suggesting a link between genomic alterations and metabolic phenotype. These findings provide new insights into the pathobiology of AC and may assist in its histopathological differentiation from other breast cancer subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class I Phosphatidylinositol 3-KinasesBreast NeoplasmsHumansFemaleMutationMiddle AgedAgedImmunohistochemistryAdultBiomarkers, TumorAged, 80 and overApocrine GlandsLipid MetabolismMetabolic Reprogramming

Substanzen

Class I Phosphatidylinositol 3-KinasesPIK3CA protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Breast Surgery, Osaka Rosai Hospital, Osaka, Japan.
  • Department of Breast Surgery, Kaizuka City Hospital, Osaka, Japan.
  • Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.

ORCID-Profile: Harumi Nakamura, Yoji Kukita

Förderung

  • Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Nakamura, H., Kukita, Y., Kittaka, N., Kusama, H., Nakayama, T., Tamaki, Y., Yoshida, K. I., Kunimasa, K., Imamura, F., & Yagi, T. (2026). Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high‐frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis. Histopathology. https://doi.org/10.1111/his.70024

Vancouver

Nakamura H, Kukita Y, Kittaka N, Kusama H, Nakayama T, Tamaki Y, et al. Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high‐frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis. Histopathology. 2026. doi:10.1111/his.70024

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Harumi and Kukita, Yoji and Kittaka, Nobuyoshi and Kusama, Hiroki and Nakayama, Takahiro and Tamaki, Yasuhiro and Yoshida, Ken-Ichi and Kunimasa, Kei and Imamura, Fumio and Yagi, Toshinari},
  title = {Apocrine carcinoma of the breast: distinctive metabolic reprogramming and high‐frequency PIK3CA mutations revealed by molecular and immunohistochemical analysis},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70024}
}
Kostenlos starten →